| Drug Type Therapeutic vaccine, mRNA vaccine | 
| Synonyms TGL 100, TGL100 | 
| Target- | 
| Action stimulants | 
| Mechanism Immunostimulants | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseClinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Head and Neck Neoplasms | Clinical | - | - | |
| Head and Neck Neoplasms | Clinical | - | - | 





